Share this with your prescribers: The threat to compounded hormone therapy affects them, too

Though APC has engaged thousands of patients and compounders in our campaign to preserve compounded hormone therapy, prescribers continue to be largely absent. It’s up to you to educate them about the threat, and we’ve developed a new resource to help you do that.

Download and ask your sales reps to share it— either a hard copy or the digital version—with all the prescribers of compounded hormones you work with. What they don’t know about FDA’s implicit threat to restrict cBHT can hurt them and their patients. Help us engage them.